226 related articles for article (PubMed ID: 7863823)
41. Renal reabsorption of inorganic phosphorus in pregnancy in relation to the calciotropic hormones.
Weiss M; Eisenstein Z; Ramot Y; Lipitz S; Shulman A; Frenkel Y
Br J Obstet Gynaecol; 1998 Feb; 105(2):195-9. PubMed ID: 9501786
[TBL] [Abstract][Full Text] [Related]
42. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
43. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Winer KK; Yanovski JA; Cutler GB
JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
[TBL] [Abstract][Full Text] [Related]
44. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
Slovik DM; Daly MA; Potts JT; Neer RM
Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone.
Kirby BJ; Ma Y; Martin HM; Buckle Favaro KL; Karaplis AC; Kovacs CS
J Bone Miner Res; 2013 Sep; 28(9):1987-2000. PubMed ID: 23505097
[TBL] [Abstract][Full Text] [Related]
46. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans.
Fraher LJ; Avram R; Watson PH; Hendy GN; Henderson JE; Chong KL; Goltzman D; Morley P; Willick GE; Whitfield JF; Hodsman AB
J Clin Endocrinol Metab; 1999 Aug; 84(8):2739-43. PubMed ID: 10443671
[TBL] [Abstract][Full Text] [Related]
48. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
Saggese G; Baroncelli GI; Bertelloni S; Perri G
J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
[TBL] [Abstract][Full Text] [Related]
49. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism.
Fatemi S; Ryzen E; Flores J; Endres DB; Rude RK
J Clin Endocrinol Metab; 1991 Nov; 73(5):1067-72. PubMed ID: 1939521
[TBL] [Abstract][Full Text] [Related]
50. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
Heshmati HM; Riggs BL; Burritt MF; McAlister CA; Wollan PC; Khosla S
J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
[TBL] [Abstract][Full Text] [Related]
51. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.
Yates AJ; Gutierrez GE; Smolens P; Travis PS; Katz MS; Aufdemorte TB; Boyce BF; Hymer TK; Poser JW; Mundy GR
J Clin Invest; 1988 Mar; 81(3):932-8. PubMed ID: 3343349
[TBL] [Abstract][Full Text] [Related]
52. Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
Transplantation; 1995 Jun; 59(12):1690-4. PubMed ID: 7604439
[TBL] [Abstract][Full Text] [Related]
53. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
Seikaly MG; Brown R; Baum M
Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
[TBL] [Abstract][Full Text] [Related]
54. Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
Podbesek RD; Mawer EB; Zanelli GD; Parsons JA; Reeve J
Clin Sci (Lond); 1984 Dec; 67(6):591-9. PubMed ID: 6548427
[TBL] [Abstract][Full Text] [Related]
55. Absence of biological effects of oxidized parathyroid hormone-(1-34) in dogs and rats.
Galceran T; Lewis-Finch J; Martin KJ; Slatopolsky E
Endocrinology; 1984 Dec; 115(6):2375-8. PubMed ID: 6499771
[TBL] [Abstract][Full Text] [Related]
56. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
Yasuda T; Nakajima H
Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
[TBL] [Abstract][Full Text] [Related]
57. Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate CA++ concentrations.
Hruska KA; Martin K; Mennes P; Greenwalt A; Anderson C; Klahr S; Slatopolsky E
J Clin Invest; 1977 Sep; 60(3):501-10. PubMed ID: 893661
[TBL] [Abstract][Full Text] [Related]
58. Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
Westerberg PA; Ljunggren O; Larsson TE; Wadström J; Linde T
Nephrol Dial Transplant; 2010 Dec; 25(12):4068-71. PubMed ID: 20525976
[TBL] [Abstract][Full Text] [Related]
59. Effects of exogenous growth hormone on bone mineralization and remodeling and on plasma calcitriol in intact pigs.
Denis I; Zerath E; Pointillart A
Bone; 1994; 15(4):419-24. PubMed ID: 7917581
[TBL] [Abstract][Full Text] [Related]
60. Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism.
Martini LA; Booth SL; Saltzman E; do Rosário Dias de Oliveira Latorre M; Wood RJ
Osteoporos Int; 2006; 17(6):929-35. PubMed ID: 16547688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
